| Name | LSP-249 | 
|---|
| Description | LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 EC50:< 100 nM (kallikrein in cell)[1].  | 
                        
| References | 
                                 [1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.  | 
                        
| Molecular Formula | C24H22ClN5O | 
|---|---|
| Molecular Weight | 431.92 | 
| Storage condition | -20°C |